Novartis AG's Fiscal Year is From January To December.
The item "Payables-Turnover" stands at 3.11 as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Payables Turnover" stands at 3.11. This represents a decrease of -1 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.03 percent compared to the value the year prior.
The 1 year change in percent is 4.03.
The 3 year change in percent is 9.82.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Payables Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Payables Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Payables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Payables Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Payables Turnover | 280,205,508,085.11 |